195 related articles for article (PubMed ID: 2974528)
1. E1A products of adenoviruses reduce the expression of cellular proliferation-associated genes.
Timmers HT; De Wit D; Bos JL; Van der Eb AJ
Oncogene Res; 1988; 3(1):67-76. PubMed ID: 2974528
[TBL] [Abstract][Full Text] [Related]
2. The repression of the growth factor-inducible genes JE, c-myc and stromelysin by adenovirus E1A is mediated by conserved region 1.
van Dam H; Offringa R; Smits AM; Bos JL; Jones NC; van der Eb AJ
Oncogene; 1989 Oct; 4(10):1207-12. PubMed ID: 2529466
[TBL] [Abstract][Full Text] [Related]
3. Differential transformation of primary human embryo retinal cells by adenovirus E1 regions and combinations of E1A + ras.
Byrd PJ; Grand RJ; Gallimore PH
Oncogene; 1988 May; 2(5):477-84. PubMed ID: 2967455
[TBL] [Abstract][Full Text] [Related]
4. E1A oncogene of adenovirus-12 mediates trans-repression of MHC class I transcription in Ad5/Ad12 somatic hybrid transformed cells.
Ge R; Liu X; Ricciardi RP
Virology; 1994 Sep; 203(2):389-92. PubMed ID: 8053163
[TBL] [Abstract][Full Text] [Related]
5. Identification of adenovirus E1A regions which affect MHC class I expression and susceptibility to cytotoxic T lymphocytes.
Pereira DS; Rosenthal KL; Graham FL
Virology; 1995 Aug; 211(1):268-77. PubMed ID: 7645220
[TBL] [Abstract][Full Text] [Related]
6. Analysis of viral and cellular gene expression during progression and suppression of the transformed phenotype in type 5 adenovirus-transformed rat embryo cells.
Duigou GJ; Su ZZ; Babiss LE; Driscoll B; Fung YK; Fisher PB
Oncogene; 1991 Oct; 6(10):1813-24. PubMed ID: 1923506
[TBL] [Abstract][Full Text] [Related]
7. Induction of integrated adenovirus E1A and E1B genes in transformed human cells by phorbol ester tumor promoters.
Carter T; James C; Chan E; Greene B
Cancer Res; 1987 Feb; 47(3):803-8. PubMed ID: 2948635
[TBL] [Abstract][Full Text] [Related]
8. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
Kohl NE; Ruley HE
Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells.
Routes JM
J Immunol; 1993 May; 150(10):4315-22. PubMed ID: 7683316
[TBL] [Abstract][Full Text] [Related]
10. Trans-activation of human MYC: the second promoter is target for the stimulation by adenovirus E1a proteins.
Lipp M; Schilling R; Bernhardt G
Oncogene; 1989 May; 4(5):535-41. PubMed ID: 2471129
[TBL] [Abstract][Full Text] [Related]
11. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
[TBL] [Abstract][Full Text] [Related]
12. Modulation of major histocompatibility complex (MHC) class I genes in adenovirus 12 transformed cells: interferon-gamma increases class I expression by a mechanism that circumvents E1A induced-repression and tumor necrosis factor enhances the effect of interferon-gamma.
Eager KB; Pfizenmaier K; Ricciardi RP
Oncogene; 1989 Jan; 4(1):39-44. PubMed ID: 2521704
[TBL] [Abstract][Full Text] [Related]
13. Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines.
Buchou T; Kranenburg O; van Dam H; Roelen D; Zantema A; Hall FL; van der Eb A
Oncogene; 1993 Jul; 8(7):1765-73. PubMed ID: 8510923
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of LFA-3, Fas and MHC Class I on Ad5- and Ad12-transformed human cells and their susceptibility to lymphokine-activated killer (LAK) cells.
Bottley G; Cook GP; Meade JL; Holt JR; Hoeben RC; Blair GE
Virology; 2005 Aug; 338(2):297-308. PubMed ID: 15963548
[TBL] [Abstract][Full Text] [Related]
15. Functions of the adenovirus E1B tumour antigens.
Stillman B
Cancer Surv; 1986; 5(2):389-404. PubMed ID: 2946407
[TBL] [Abstract][Full Text] [Related]
16. Induction of differentiation-regulated transcription factor Oct-6 specifically accompanies major histocompatibility complex class I down-regulation by E1A of oncogenic adenovirus type 12.
Peeper DS; Schouten GJ; Toebes M; Meijer D; Zwart R; van de Woude I; van Schaik H; van der Eb AJ; Zantema A
Cell Growth Differ; 1995 Aug; 6(8):977-84. PubMed ID: 8547226
[TBL] [Abstract][Full Text] [Related]
17. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of major histocompatibility complex class I expression and susceptibility to natural killer cells in cells transformed with the oncogenic adenovirus 12 are regulated by different E1A domains.
Huvent I; Cousin C; Kiss A; Baroni de Moraes MT; Bernard C; D'Halluin JC
Cancer Detect Prev; 1997; 21(1):12-21. PubMed ID: 9043758
[TBL] [Abstract][Full Text] [Related]
19. Region E1a of highly oncogenic adenovirus 12 in transformed cells protects against NK but not LAK cytolysis.
Kenyon DJ; Raska K
Virology; 1986 Dec; 155(2):644-54. PubMed ID: 2947382
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus E1A-p105(Rb) protein interactions play a direct role in the initiation but not the maintenance of the rodent cell transformed phenotype.
Nielsch U; Fognani C; Babiss LE
Oncogene; 1991 Jun; 6(6):1031-6. PubMed ID: 2067843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
